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Caloric restriction (CR), defined as decreased nutrient intake without causingmalnutrition,
has been documented to increase both health and lifespan across numerous organisms,
including humans. Many drugs and other compounds naturally occurring in our diet
(nutraceuticals) have been postulated to act as mimetics of caloric restriction, leading
to a wave of research investigating the efficacy of these compounds in preventing
age-related diseases and promoting healthier, longer lifespans. Although well studied at
the biochemical level, there are still many unanswered questions about how CR and CR
mimetics impact genome function and structure. Here we discuss how genome function
and structure are influenced by CR and potential CRmimetics, including changes in gene
expression profiles and epigenetic modifications and their potential to identify the genetic
fountain of youth.
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INTRODUCTION
The aging process is undoubtedly the single most significant contributor to disease and death.
Although this has been the inevitable outcome of all life on this planet, is aging an unavoidable
consequence or can it be treated and potentially cured? As of yet this question remains unanswered,
butmany believe that the aging process is essentially a disease. Environmental conditions, including
lifestyle, can greatly affect the rate of aging. For example, obesity or excessive ingestion of calories
has been linked to increased incidents of age-related pathologies such as diabetes, cardiovascular
disease, stroke, type II diabetes, and cancer development (Fontana and Klein, 2007). Several
lines of research indicate that certain behaviors can increase our health and potentially lifespan,
such as exercise and regimes to improve cardiovascular function. One such intervention is the
use of dietary/caloric restriction (CR); the reduced intake of calories/nutrients without causing
malnutrition. This was first recognized over 80 years ago in dietary restricted rats exhibiting
increased mean and maximal lifespans (McCay et al., 1935). In recent years, this observation has
been verified across a large number of model organisms (Longo, 2009; Lee and Longo, 2016). These
observations not only demonstrated an increase in the lifespan, but also in healthspan (time spent
being healthy) of these organisms coincident with a significant decrease in age-related pathologies
such as cardiovascular disease, diabetes and a number of cancers. For example, when fed a diet
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consisting of 35% of the ad libitum intake but enriched with
vitamins and minerals, mice lived an average of 53 months,
compared to 35 months in the control ad libitum-fed group
(Weindruch et al., 1986). In addition, preliminary research
indicates that CR prior to chemotherapy in humans increases
tumor responsiveness while reducing side effects (Lee and Longo,
2011). Several drugs or naturally occurring compounds in food
(nutraceuticals) have been found to “mimic” the phenotypes of
CR (Lee and Min, 2013) and could be potential alternatives to
this somewhat difficult to follow dietary regime. An obvious first
question: Do these compounds mirror the effects of CR? A large
body of outstanding research focuses on the impact of CR and
mimetics on autophagy (self-eating) in the regulation of longevity
and in promoting apoptosis in cancer cells [from groups such as
Drs. S. Pattingre and G. Kroemer (for an extensive review see
Klionsky et al., 2008)]; however, the mechanism and impact on
genome function (gene expression) and organization (epigenetic
changes and physical genome folding) are less well understood.
In this review, wewill discuss the effect of CR on genome function
and structure and compare the impact of CR mimetics in an
attempt to gage their ability to increase health and lifespan at the
genetic level.
POTENTIAL IMPACT OF CR ON HOW WE
AGE
Four major theories have been proposed to explain how/why we
age. These theories include; increased reactive oxygen species
(ROS) and decreased DNA repair, increased circulating glucose
and insulin, increased circulating growth hormone and insulin-
like growth factor-1 and the hormesis hypothesis. CR has been
shown to promote increased lifespan and slow the aging process
(see Figure 1 for a brief summary). How does CR exhibit these
effects and fit in within these proposed theories?
CR REDUCES LEVELS OF REACTIVE
OXYGEN SPECIES AND INCREASES DNA
REPAIR
The oxidative damage attenuation hypothesis states that
increased metabolism from high levels of nutrients/calories leads
to higher rates of ROS and that lowering these levels will prevent
lipid, protein and DNA damage (Ray et al., 2012). Damage such
as this would lead to decreased function of cellular components
as well as to increased rates of mutation. However, the other
side of this hypothesis states that lower metabolic rates results in
decreased rates of DNA damage and increased genome stability,
and thus in fewer incidents of cancer. This in itself would
promote increased lifespan through improved genomic “health.”
Furthermore, CR resulted in a reversal of age-related DNA
damage in multiple mouse tissues by inducing genes from the
base excision repair (BER) pathway (Cabelofa et al., 2003) and
by modifying the activity of the Ku70/80 proteins (Um et al.,
2003). In addition, many of the premature aging diseases, such
as Werner syndrome (Sidorova, 2008) and Hutchinson Gilford
Progeria syndrome (HGPS; Cao et al., 2011; Musich and Zou,
2011), have increased levels of DNA damage and lower rates
of DNA repair. The rapid accumulation of DNA damage likely
drives these cells into premature senescence leading to rapid
onset of aging-phenotypes. Although this is logical, some data
does indicate that there is not a significant enough change in free
radical production upon CR to significantly decrease ROS levels
(Miwa et al., 2004) indicating that the benefits of CR might not
be elicited through this mechanism.
Although CR increases lifespan, it may not be due to
a reduction of the ROS levels produced by mitochondria
(Miwa et al., 2004), but may result from an increase in
the expression of enzymes that protect against these highly
reactive molecules, reducing net oxidative stress. However, in
D. melanogaster exposed to CR, no link between lifespan
extension and increased resistance to oxidative stress has been
found. Furthermore, CR of older flies significantly decreases
resistance to oxidative stress with both cytosolic superoxide
dismutase 1 (SOD1) and mitochondrial SOD2 unresponsive to
CR, contrary to the proposal that CR causes life span extension
by increasing resistance to oxidative stress (Kabil et al., 2007).
These observations support the suggestion that CR may not elicit
its beneficial properties via reduction in ROS or resistance or
oxidative stress.
CR DECREASES CIRCULATING GLUCOSE
AND INSULIN
The altered glucose-insulin hypothesis indicates that CR causes
a decrease in the circulating levels of both insulin and
glucose, leading to decreased insulin signaling. This is based
on observations that decreased insulin signaling promotes
increased lifespan in a variety of model organisms, including
C. elegans (worms; Murphy and Hu, 2013), D. melanogaster
(flies; Kannan and Fridell, 2013), and M. musculus (mouse;
Zhang and Liu, 2014). Increased glucose and insulin in the
circulatory system will cause peripheral cells to absorb this
glucose and convert it to ATP. In addition, insulin will
also send positive growth and proliferative signals, pushing
cellular balance toward growth and cell division. Increased
metabolism will produce ROS from mitochondria as well as
shortening the time in which cells repair or replace old or
damaged molecules. Although enough energy is present to
produce daughter cells, these rapid rates of cell division may
be harmful. Therefore, CR may promote increased lifespan
by decreasing rates of cell division and favoring repair and
maintenance.
CR DECREASES CIRCULATING GROWTH
HORMONE (GH) AND INSULIN-LIKE
GROWTH FACTOR-1 (IGF-1)
The growth hormone-IGF-1 axis hypothesis states that increased
signaling through these pathways advances the aging process
by promoting cell growth and proliferation. Similarly to the
glucose-insulin level hypothesis, CR causes the reduction of
growth hormone/IGF-1 signaling (Fontana et al., 2015), favoring
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FIGURE 1 | Caloric restriction and the four hypotheses of aging. Four major theories of aging; oxidative damage attenuation hypothesis (green), glucose-insulin
hypothesis (yellow), growth hormone and insulin-like growth factor (IGF)-1 (blue), and the hormesis hypothesis (orange). Oxidative damage is decreased during caloric
restriction (CR), through decreased production of reactive oxygen species and the up-regulation of protective enzymes, resulting in a decrease in DNA damage and
increase in genome stability. CR causes decreased levels of circulating insulin and glucose, resulting in decreased cell growth and division, shifting toward
maintenance and repair. Decreased levels of growth hormone and IGF-1 in response to CR, promoting maintenance and repair. CR is inducing a low level of stress
which enables cells to counteract higher stresses, increase DNA repair gene expression and favor maintenance and repair.
a switch from cell growth and proliferation to maintenance and
repair in mice. CR phenotypes parallel long lived Ames and
Snell dwarf mice, with either decreased GH receptor activity
or knock-outs of the growth hormone binding protein gene
exhibiting hepatic synthesis of IGF-1, reduced secretion of
insulin, increased hepatic sensitivity to insulin, reduced plasma
glucose, and increased resistance to oxidative stress (Brown-
Borg and Bartke, 2012). However, in human studies Fontana
and colleagues documented that over a 2 year period of CR, no
change in circulating IGF-1 levels were observed (Fontana et al.,
2008, 2015). These findings hint at two potential conclusions;
(1) CR does not work in humans, only in mice, or (2)
CR does not impact IGF-1 levels; however, it does impact
other pathways, leading to at least increased healthspan, if not
lifespan.
CR ALTERS CELL BEHAVIOR FROM
PROLIFERATION AND GROWTH TO
MAINTENANCE AND REPAIR
The hormesis hypothesis states that low levels or intensity
of stress leads to “priming” in which cells/tissues/organs can
then withstand other stresses that would normally prove
terminal. It is thought that with hormesis, cells move from
active growth and proliferation to a state that favors repair
and maintenance. CR may prime cells by activating stress
pathways to deal with later assault such as DNA damage. CR
is documented to increase the expression of genes involved
with DNA repair (Cabelofa et al., 2003) which will increase
the efficiency at which cells are able to cope with, for example,
oxidative damage. Other specific observations appear to favor
this model, activating transcription factors and mechanisms
controlling gene expression leading to increased levels of
proteins mediating cellular stress responses (Calabrese et al.,
2011).
HOW ARE NUTRIENTS SENSED AT THE
CELLULAR LEVEL?
Although it is clear that CR promotes increased health and
lifespan (although this is controversial in primates) several
questions still remain unanswered. For example, do all cell
types share common mechanisms mediating CR to promote
increased cell longevity? Two major cellular energy sensors
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FIGURE 2 | The downstream effects of caloric restriction on key aging mediators AMPK and SIRT1. CR results in decreased mitochondrial function,
increasing the ratio of AMP:ATP and levels of NAD+. Increased AMP:ATP ratio leads to activation of AMPK. Furthermore, AMPK is phosphorylated/activated by LKB1
and SIRT1-mediated deacetylation, generating a feedback loop. AMPK inhibits glycogen synthesis, fatty acid oxidation, HMG-Co-A Reductase, and mTOR function
(indirectly through phosphorylation of the TSC1/2 complex; not shown). Decreased mTORC1 function results in; increased autophagy, decreased S6K activity and
cap mediated protein translation, inhibits HIF-1α, resulting in reduced cell cycle progression, angiogenesis and glucose metabolism. Increased NAD+ levels promote
SIRT1 activity, resulting in deacetylation of LKB1 and AMPK, and upregulation of their respective function. CR enables binding of FOXO3a and p53 in the promoter of
SIRT1, further driving SIRT1 expression. Activated SIRT1 deacetylates the RelA/p65 component of NFκB, preventing degradation of IκB and sequestering NF-κB in
the cytoplasm, inhibiting proinflammatory gene expression. SIRT1 also promotes establishment and maintenance of heterochromatin and decreases cell growth and
proliferation.
have been identified, the adenosine monophosphate kinase
(AMPK) and the Sirtuin 1 (SIRT1) deacetylase (Figure 2).
AMPK is activated as the ratio of cellular AMP:ATP rises,
indicating low levels of energy. AMPK regulates both catabolic
and anabolic processes in response to energy levels (Gowans
and Hardie, 2014) and has a variety of targets. When active,
AMPK inhibits glycogen synthesis, fatty acid oxidation and
HMG-Co-A reductase (Lim C. T., et al., 2010). Further, it
has been suggested that chronic activation of AMPK results
in expression of muscle hexokinase and glucose transporters
(Glut4), mimicking the effects of extensive exercise training
(Zhou et al., 2001). AMPK further activates proteins involved
with fatty acid hydrolysis, glucose up-take and p53 signaling.
Downstream of AMPK is the target of rapamycin (TOR)
signaling cascade. TOR is evolutionarily conserved and functions
in mediating growth and environmental cues; therefore, it likely
plays a central role in regulating cellular responses to CR
and CR mimetics. Comprised of two individual complexes,
TORC1 and TORC2 (Yang et al., 2013), TOR further mediates
signals from a variety of upstream cascades, including the
insulin (Bjedov et al., 2010; Verges and Cariou, 2015) and
PI3K pathways (Massacesi et al., 2016). Low cellular energy
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levels promote AMPK to phosphorylate tuberous sclerosis
complex (TSC)-1 and 2 which in turn inhibit TORC1. This
decrease in TORC1 function leads to decreased S6 kinase
phosphorylation, leading to decreased rates of cap-mediated
protein translation. AMPK has also been shown to activate and
repress specific transcription factors involved with modulating
gene expression. AMPK also phosphorylates SIRT1, further
leading to its activation. SIRT1 is stimulated in response to
decreased energy levels, leading to an increase in cellular
concentration of nicotinamide adenine dinucleotide (NAD+;
Lau et al., 2014). SIRT1 deacetylates both histone and non-
histone targets, in the nucleus and the cytoplasm, leading to
changes in cellular function and gene expression. One of the
targets of SIRT1 is the LKB1 kinase. When LKB1 is deacetylated,
it phosphorylates AMPK, further driving AMPK activation. Both
AMPK and SIRT1 have common targets, such as p53, implicating
these proteins as central in controlling CR mediated changes in
gene expression and cellular function, leading to increased health
and longevity.
Parallel to AMPK, the General Control Nonderepressible
(GCN2) factor detects decreased levels of amino acids
through sensing of uncharged tRNAs. GCN2 decreases
rates of translation, preserving limited pools of amino acids
as well as conserving energy (Chantranupong et al., 2015).
Furthermore, GCN2 activates the ATF4 transcription factor
which then regulates the expression of genes involved with
apoptosis, autophagy, and amino acid metabolism, including
up-regulation of select amino acyl tRNA synthetases and amino
acid transporters (Harding et al., 2000, 2003; Bunpo et al.,
2010; B’Chir et al., 2013; Krokowski et al., 2013). Furthermore,
Sestrin2 binds the pentameric GTPase activating TOR (GATOR)
2 complex under amino acid depleted conditions (in particular
leucine), releasing GATOR1 which then bind and inhibits
RAG GTPase complexes required for mTORC1 activation
(Chantranupong et al., 2015). The location of both AMPK,
GCN2 and Sestrin2/GATOR2, as well as many other growth
factors pathways, upstream of TOR indicates that TORC1 and 2
are likely the center points mediating growth and environmental
signals.
Although much is known about the cytosolic sensing of
nutrients, how do these sensors link to the genome and impact
gene expression? Furthermore, does the activation/inactivation
of different proteins from these pathways stimulate the same
sets of genes or impact the genome using common mechanisms?
Are there tissue specific targets that mediate differing responses
dictating how a specific cell type will react to changes in
nutrient availability? When considering interfering with these
pathways, does disruption at different points result in different
patterns of gene expression and are these equivalent to CR
itself? We know that signaling complexes such as TORC1
interact with a variety of transcription factors, including Hypoxia
Inducible Factor 1α (HIF1α) and Peroxisome Proliferator-
Activated Receptor γ (PPARγ summarized by Laplante and
Sabatini, 2013). We will discuss some of these factors and their
impact on genome function following CR or in response to CR
mimetics.
WHAT ARE THE MECHANISMS DRIVING
CHANGES IN GENE EXPRESSION
FOLLOWING CR?
CR restriction in yeast stimulates stress response transcription
factors Msn2/4 and Gis1. Under normal conditions, these
factors are inhibited by TOR and the yeast homolog of the S6
kinase, Sch9 (Vidan and Mitchell, 1997; Roosen et al., 2005;
Swinnen et al., 2006). However, deletion of Msn2/4 and Gis1
only partially impact the CR stress response, indicating that
other factors also mediate this reaction (Wei et al., 2008).
Further, signaling to transcription factors is also indicated in
Sch9 deletion mutants which demonstrate a 10-fold increase
in lifespan (Wei et al., 2008). CR induces the function of
the pyrazinamidase/nicotinamidase 1 (PNC-1) enzyme which
deaminates and depletes nicotinamide (Anderson et al., 2003).
Over expression of PNC-1 under normal nutrient conditions
extends yeast lifespan by 70%. The induction of PNC-1 was
not affected by deletion of the Msn2/4 transcription factors,
indicating that these factors are dispensable for PNC-1 mediated
lifespan extension under conditions of decreased glucose.
One of the major factors activated under conditions of
nutrient sensing is the Sirtuin (SIRT) family of deacetylase
proteins that are dependent on NAD+ which are high under
conditions of nutrient deprivation (B’Chir et al., 2013). Although
primarily known for their role as a histone deacetylase,
SIRT proteins also target a large number of nuclear and
cytosolic proteins. The extension of lifespan in yeast is linked
to PNC-1 mediated deamination of nicotinamide leading to the
activation of the Sir2 (yeast homolog of mammalian SIRT1)
protein (Gallo et al., 2004). In mice, CR up-regulates the
expression of SIRT1 (Cohen et al., 2004; Nemoto et al., 2004)
while over expression of SIRT1 promotes phenotypes resembling
that of CR (Bordone et al., 2007). Parallel to the increased
NAD+ levels, SIRT1 is further stimulated directly by activated
AMPK which deacetylates the tumor suppressor p53, inhibiting
transactivation and p53-mediated gene expression (Giannakou
and Partridge, 2004; Demidenko et al., 2009). SIRT1 function
may be pivotal in defining how cells respond to stress induced
by CR to promote longevity, whereas other stresses, such as
DNA damage, lead to p53-mediated senescence or apoptosis.
Somewhat paradoxically, sir21 yeast mutants exhibit increased
resistance to oxidative stress and heat, indicating a pro-longevity
phenotype (Fabrizio et al., 2005). These findings may indicate
that the impact of Sir proteins may have divergent roles in
chronological (total time) vs. replicated (number of cell divisions)
lifespan (Longo, 2009).
SIRT1 activation via CR also results in decreased levels of
inflammation by down regulation of genes encoding cytokines
(Spaulding et al., 1997; Kalani et al., 2006; Meydani et al., 2014).
In macrophages, SIRT1 activation results in deacetylation of
the RelA/p65 component of nuclear factor-κB (NF-κB) complex
(Stein and Matter, 2011). NF-κB is normally sequestered in
the cytoplasm by its repressor Inhibitor of κB (IκB). Under
conditions of stress, IκB is phosphorylated by the IK kinase
(IKK) complex, leading to IκB dissociation from NF-κB. IκB
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is degraded and NF-κB translocates to the nucleus where it
binds DNA and facilitates increased gene expression of pro-
inflammatory genes. In addition, increased NF-κB function is
observed in cells from older individuals (Kriete et al., 2008;
Bektas et al., 2014). Acetylation at residue lysine 310 of RelA/p65
activates NF-κB, whereas removal of this acetyl group by SIRT1
inactivates the complex resulting in decreased expression of
pro-inflammatory genes (Opalach et al., 2010). CR attenuated
the age-mediated effects of NF-κB, resulting in more inhibitor
IκB and decreased levels of RelA/p65 in a number of model
organisms (Opalach et al., 2010). Furthermore, CR caused a
reduction in the constitutive activation of p65 observed in
CT-2A malignant mouse astrocytoma cells, inducing apoptosis
(Mulrooney et al., 2011), thus supporting the hypothesis that CR
is a viable treatment strategy for patients with aggressive brain
cancers (Mukherjee et al., 2004).
The forkhead family transcription factor, FOXO3a, also
known as DAF-16 in C. elegans, is a key regulator of the insulin
receptor (IR)/insulin-like growth factor-I signaling pathway
mediated extension of lifespan. CR stimulates the hyper-
phosphorylation of FOXO3a leading to exclusion from the
nucleus. This exclusion from the nucleus corresponded to an
attenuation of Alzheimer’s disease in Tg2576 mice (a specific
model strain used for the study of Alzheimer’s disease), indicating
a link between CR, FOXO3a and age-related neurological
pathologies (Qin et al., 2008). Other mammalian homologs of
Daf-16 in mice; however, show signs of increased expression
during CR, indicating that these factors may be involved in
promoting increased longevity in muscle cells (Furuyama et al.,
2002). However, this study did not specify if these factors
were prevented from becoming nuclear, indicating that there
may be a cytosolic role for FOXOs, facilitating autophagy and
extending lifespan. In addition, SIRT2 deacetylates FOXO3a in
mice (Brunet et al., 2004; Daitoku et al., 2004; van der Horst
et al., 2004), resulting in increased DNA binding of FOXO3a
and expression of FOXO target genes, p27-Kip1, manganese
superoxide dismutase (Kops et al., 2002), catalase (Furuyama
et al., 2000; Nemoto and Finkel, 2002), and under conditions
of severe stress, deacetylates and activates the pro-apoptotic
protein Bim/BCL2L11 (Wang et al., 2012). In addition to these
genes, FOXO3a also targets a variety of genes involved in several
processes, including G1 arrest, G2 delay, DNA repair, ROS
response, and glucose metabolism. Expression of SIRT1 is also
dependent on the physical interaction of FOXO3a with p53 to
promote binding within the SIRT1 promoter under conditions of
decreased nutrient availability (Nemoto et al., 2004). In a separate
experiment, knockout of FOXO3a in mice demonstrated that
they no longer benefit from CR, indicating that this transcription
factor is central in regulating genes that promote increased health
and lifespan (Shimokawa et al., 2015), possibly mediating the
interaction and functions of SIRT1 and p53. These observations
strongly link SIRT1, p53, and FOXO3a in mediating a stress
response in cells that favors a decrease in cell growth and
proliferation without resulting in cell death.
Members of the PPAR nuclear receptor family PPARα,
PPARβ/δ, and PPARγ are involved with regulating insulin
sensitivity, adipogenesis, lipid metabolism, and blood pressure
(Brown and Plutzky, 2007). Numerous polymorphisms have
been identified in the PPAR genes that are directly related
to type II diabetes and metabolic syndrome, indicating the
pivotal role of these receptors in regulating gene expression in
response to diet. PPARγ directly interacts with SITR1 under
normal conditions. Diets which promote the formation of
advanced glycation end products (AGEs) in diabetic patients and
older individuals causes a decrease in both of these proteins
(Singh et al., 2014). This decrease in PPARγ and SIRT1 further
corresponds to an increase in inflammation. Restricting the
dietary intake of AGEs in combination with CR re-established
SIRT1 and PPARγ expression, decreasing the inflammatory
response (Uribarri et al., 2015). CR as a treatment for disease
represents a specific challenge when considering PPARmembers.
Although CR reduces the activity of PPARs through decreased
activation, this leads to a decrease in the expression of genes
regulating fatty acid metabolism. This results in the build-up
of fatty acids in the liver causing steatosis/fatty liver disease.
Paradoxically, Oshida and colleagues report that triglycerides
directly activate PPARα during fasting or CR, both leading to cell
proliferation and inhibition of inflammation (Oshida et al., 2015),
demonstrating that both indirect and direct mechanisms control
PPAR function.
CR decreases the expression of HIF-1α–mediated genes (Chen
et al., 2009). HIF-1α activity is associated with a variety of other
physiological stimuli such as heat acclimation, acidosis, nitric
oxide exposure, inflammation and oxidative stress (Reviewed by
Kang et al., 2005). In addition, HIF-1α activity is increased in
aged rats, up-regulating genes such as heme oxygenase-1 (HO-1),
vascular endothelial growth factor (VEGF), erythropoietin (EPO),
and inducible nitric oxide synthase (iNOS; Kang et al., 2005),
with CR demonstrated to decrease the expression of these genes.
CR may facilitate this process through the inhibition of mTOR
signaling and decreased protein translation. Several studies have
demonstrated that HIF-1α translation is dependent on mTOR
activity (Bernardi et al., 2006; Hui et al., 2006). Repression of HIF-
1α, therefore, leads to decreased levels of several genes including
those regulating cell cycle progression, angiogenesis, and glucose
metabolism (reviewed in Hong et al., 2004). In addition, SIRT1
(which is up-regulated under conditions of CR) deacetylates
HIF1α preventing recruitment of the acetyl transferase p300
and further inactivation of HIF-1α target genes (Lim J. H.,
et al., 2010). HIF-1α also interacts with the redox factor REF-
1, which is also involved with NF-κB signaling, indicating that
both HIF-1α and NF-κB may respond in parallel under nutrient-
rich conditions. Therefore, the repression of both the NF-κB and
HIF-1α responses by CR may be analogous reactions to prevent
inflammatory or stress responses that could potentially lead to
carcinogenesis.
GENOME WIDE IMPACT OF CR ON GENE
EXPRESSION/GENE PATHWAYS
A large number of gene expression studies have been performed
in order to determine the impact of CR on genome function.
CR is well known to elicit a change in cell behavior marked by
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a decrease in cell proliferation and shift to cellular maintenance
and repair. Changes in phenotype are accompanied by changes
in gene expression; therefore, what impact does CR have on gene
expression from across the genome? CR of yeast caused 646 genes
to significantly change expression leading to lifespan extension
(Choi et al., 2013). These genes were identified to be positively
correlated with transcriptional regulation, ribosomal processing
and genome stability and negatively correlated with pathways
involved with metabolism or cell cycle progression. Analysis of
these genes indicated that the transcription factors Azoospermia
Factor 1 (AZF1), Heatshock Factor 1 (HSF1), and X-box binding
protein (XBP1) were involved with mediating lifespan extension
under conditions of CR due to decreased glucose levels (Choi
et al., 2013). These factors are involved with regulating stress
response, indicating that CR may function as a cellular stress
which promotes hormesis in yeast.
Whitaker and colleagues demonstrate that the timing of the
gene expression analysis is critical in determining which genes
are central in mediating increased longevity in response to CR
(Whitaker et al., 2014). It was suggested that a small number
of genes will rapidly be induced while secondary effects from
initial changes would be observed at later time points. In this
study, 853 genes were identified that changed expression over a
40 day period in D. melanogaster. Genes that changed expression
demonstrated enrichment in pathways associated with folate
biosynthesis, ubiquinone/terpenoid-quinone biosynthesis, and
oxidative phosphorylation (Whitaker et al., 2014). Of these
genes, very few were in common with starvation. Those that
were common appeared to change expression in the opposite
direction indicating that the response to CR is divergent from
extreme nutrient deprivation (Whitaker et al., 2014). In support
of this, starvation of D. melanogaster larvae exhibited differential
activation of specific genes (Zinke et al., 2002) indicating
that different levels of nutrients or duration may also impact
expression profiles.
In an another meta-analyses, Swindell and colleagues
identified more than 10,000 differentially expressed genes
from over 40 independent datasets (Swindell, 2009). A meta-
analyses of gene expression profiles in mammalian systems
demonstrated that CR resulted in gene expression changes
involved with a number of biological pathways, including growth
hormone signaling, lipid metabolism, immune response, retinol
metabolism, copper ion detoxification, and circadian rhythms
(Whitaker et al., 2014). The large number of genes observed to
have changed expression is likely due to many factors, including
the use of expression data from different species, tissues and
time points as well as also identifying secondary effects. It is
more likely that in response to CR a few genes will have altered
expression which leads to changes in cellular function and other
secondary effects.
The identification of CR influencing circadian rhythm
pathways (Swindell, 2009) and genes related to circadian
rhythms is intriguing, demonstrating that diet can also affect
sleep patterns, further impacting health. H3K4me3 deposited
by the Mixed-lineage Leukemia 1 (MLL1) methyltransferase
regulates the binding of the core transcription factors, circadian
locomotor output cycles kaput (CLOCK) and BMAL1,
controlling the cyclic expression of clock-controlled genes
(CCGs). Indeed, the link between diet and circadian rhythms
is likely mediated through SIRT1 function, with NAD+ levels
influencing the epigenetic modification and expression CCGs
therefore impacting biological rhythms (Aguilar-Arnal et al.,
2015). Furthermore, AMPK phosphorylates the cryptochrome
protein, resulting in the inhibition of CLOCK-mediated CCG
expression (Masri and Sassone-Corsi, 2013). This provides
further evidence for levels of cellular energy being essential
in regulating health promoting biological processes such as
circadian rhythms.
Contrary to the finding of Swindell and colleagues, another
meta-analysis of microarray datasets from mouse, rats and
pigs measuring gene expression changes as a result of CR
demonstrated that only a handful of genes (101 up-regulated
and 73 down-regulated) across multiple experiments. The
Gene Ontology (GO) terms for these genes demonstrated
enrichment in processes related to lipid metabolism and Acetyl-
CoA reductase activity (Plank et al., 2012). In addition, terms
for processes related to circadian rhythms were also identified
in over expressed genes while down regulated genes showed
enrichment for GO terms related to steroid biosynthesis, reduced
transcription of genes involved with sterol biosynthesis and
innate immune-response. However, the low number of genes
identified over meta-analyses may reflect the heterogeneity
created by using cross species comparisons and more candidates
involved with CRmay have been overlooked. Microarray analysis
of multiple mouse tissues also indicated that there are tissue
specific changes in gene expression related to CR (Park and
Prolla, 2005). In an additional study of gene expression of muscle
from male mice (Weindruch et al., 2001), microarray analysis
demonstrated that only 58 genes were up-regulated and 55
genes were down-regulated. Of the 58 up-regulated genes, 16%
were related to stress response and coincided with an increase
in ROS produced in older mice. Many of these genes were
either completely or partially repressed in CR mice fed 76%
of the calories of mice on control diets. CR itself induced the
expression of 51 genes, many of which were related to energy
metabolism. Furthermore, CR increased the expression of genes
involved with detoxification, which are hypothesized to decrease
normally with age (Fu and Klaassen, 2014). An examination
of 98 xenobiotic processing genes not only demonstrated an
increase in expression of these genes, but also that CR favored the
expression of female pre-dominantly expressed genes over pre-
dominantly male expressed detoxification genes in the livers of
male mice. These findings indicate that the CR may be inducing
a shift toward maintenance and repair and re-establishing the
expression of genes involved with detoxification, supporting the
hormesis model.
Despite this plethora of publications regarding the impact of
CR on genome function, there appears to be little consensus
as to the genes that are responsible for promoting increased
health and lifespan. This may be due to the complexity of
the responses and differing mechanisms not only between cell
types within the same organisms but also differing response
between systems. Furthermore, the observation by Whitaker and
colleagues indicating that the timing of analysis will be pivotal
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(Whitaker et al., 2014) highlighting the challenges underling
the identification of genes controlling CR mediated impacts on
health and lifespan. We will also note at this point that there is
still controversy surrounding the impact of CR on longevity. For
example, Harper et al. (2006) suggest that CR has no significant
impact onmice outside of the laboratory setting. One explanation
for this is that the CR regimes imposed by laboratories is too
strict when compared to wild mice. Furthermore, wild mice
also have more complex genetic backgrounds and diversity in
their populations. To further complicate these issues, Mattison
et al. (2012) indicated no impact on the survival of young or
old rhesus monkeys exposed to CR. Regardless, both mice and
rhesus monkeys did demonstrate an increase in healthspan and
fewer age-associated pathologies in response to CR, arguing that
although a statistical significance in lifespan is debatable, the
evidence supporting a positive impact on health is strong. The
complexities of these analyses may indicate that each cell/tissue
type may have different genes that are active or inactivated as a
result of CR.
EPIGENETIC CHANGES IN RESPONSE
TO CR
Critical to this discussion is the subject of epigenetics. Although
the primary sequence of the genome is of obvious importance,
with mutations in critical genes either promoting or shortening
health and lifespan, it is not the only consideration when
contemplating the impact of CR or CR mimetics. During the
aging process our epigenome, the collection of epigenetic marks
including histone modifications and CpG island methylation,
is altered. For example, there is a genome-wide loss of
histone 3 lysine 27 trimethylation (H3K27me3) and CpG island
methylation resulting in the reactivation of repressed genes.
This represents a loss of gene regulation, thus promoting cancer
development (Issa et al., 1994, 2001; Knapowski et al., 2002).
In prematurely aging HGPS cells, there is a distinct lack of
heterochromatin with genome-wide loss of gene regulation
(Kubben et al., 2012). Paradoxically, there are some CpG islands
near promoters that become hypermethylated during aging
(Singhal et al., 1987; Johnson et al., 2012), which results in
the repression of nearby genes. Although the accumulation of
mutations over time will impact genome function, another major
driver of cellular aging is the loss of repressive epigenetic marks.
These changes in epigenetic marks lead to changes in gene
expression profiles, therefore, it is important to consider how CR
impacts methylation and epigenetic marks across the genome.
Calories and nutrients from our diet are one of the most
reliable, efficient and profound environmental factors leading to
alteration in health and lifespan (Weindruch et al., 1986; Sinclair,
2005). CR is able to mediate specific changes in gene methylation
profiles. For example, hypermethylation of the c-myc oncogene
was observed in mice exposed to CR (Miyamura et al., 1993),
which also lead to hypermethylation of the ras oncogene in rat
pancreatic cells (Haas et al., 1993). These observations indicate
that diet and cellular energy levels impact some of the most well
characterized regulators of cancer and that this link is not a new
phenomenon. Furthermore, the diets of our parents will play a
large role in the profiles of our genomic function regardless of
mutations within genes. A strong piece of evidence supporting
the importance of epigenetics is the study from the Kim group;
genome-wide sequencing of super-centenarians (110 years or
older) demonstrated no significant enrichment for any single
rare genetic variant to explain this longevity as compared to
control genomes (Gierman et al., 2014). It is, therefore, likely
that epigenetic modification to either histones or CpG islands
due to environmental or maternal influences are responsible. In
addition, CR prior to or during pregnancy can greatly impact
the health and life span of offspring. CR of parents either
prior to or during pregnancy has also shown to have benefits
in the offspring, further supporting the role of epigenetics in
regulating and increasing lifespan. Transgenerational epigenetic
inheritance (the impact of environment on epigenetic status that
is then passed to offspring) has been described in a diverse
range of organisms ranging from plants to mammals. In C.
elegans, knockdown of chromatin modifiers related to H3K4me3
in the F0 generation showed increased lifespan of offspring in
the F3 generation, indicating a role for epigenetics in controlling
inherited longevity (Greer et al., 2011). However, this does not
appear to be the case with CR. In mice, CR prior to (1 month
before pregnancy) or during pre-pregnancy leads to decreased
health in offspring two generations later (Ponzio et al., 2012;
Palou et al., 2015). CR of non-human primates during pregnancy
also impacts the development of kidneys in the offspring, leading
to decrease numbers of glomeruli (Nijland et al., 2007). This
change in kidney development also corresponded to changes
in gene expression from a number of different pathways,
including the up-regulation of steroid metabolism and mTOR
genes, and down-regulation of genes associated with oxidative
phosphorylation, amino acid metabolism and cytokine-cytokine
receptor interactions (Nijland et al., 2007). Therefore, despite
not always having a positive impact, it is clear that CR, as well
as other environmental factors experienced by the parents, has
transgenerational epigenetic impact on the offspring influencing
health and lifespan.
SIRT1 may also play a role in the establishment and
maintenance of heterochromatin as a function of aging and
CR. Endogenous SIRT1 can mediate the deacetylation of H4K16
and H3K9 leading to increased levels of H3K9me3, histone H1
recruitment, facilitating heterochromatin formation (Vaquero
et al., 2004). This links SIRT1 deacetylase function not only with
the regulation of specific factors and decreased gene expression
but also to repression of specific loci and heterochromatin
maintenance. This link is strengthened through the observation
SIRT1 deacetylates and activates SUV39H1 methyltransferase
(Vaquero et al., 2004, 2007) responsible for the deposition on
methyl marks on H3K9 residues. This indicates that SIRT1
activity during CR is key in maintaining gene expression profiles
through the deacetylation of genomic regions as well as the
modulation of other proteins involved with chromatin structure.
What are some of the specific loci that are regulated by
changes in epigenetic status in response to CR? In normal lung
fibroblasts (WI-38) deprived of glucose, there is a marked change
in epigenetic status with p16-ink promoter regions becoming less
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acetylated and hypermethylated. This change in acetylation and
methylation causes p16-ink inactivation in leading to decreased
cell proliferation (Li et al., 2010a). Contrary to this, the human
Telomerase (hTERT) gene which encodes the main catalytic
subunit of the telomerase enzyme, was activated becoming
more acetylated and hypomethylated (Li et al., 2010a). These
effects were opposite in immortalized cells, demonstrating a
significant reduction in methylation with the p16-ink promoter
and an increase in acetylation. The hTERT promoter became
enriched for H3K9me3 and deacetylated in response to glucose
withdrawal. The introduction of 5-aza-cytosine or trichsostatin A
(TSA) reversed these effects, indicating that there is an epigenetic
response of these promoters to glucose deprivation. Glucose
deprivation (CR) promoted cell cycle arrest in normal fibroblasts
while causing apoptosis in immortalized cells, demonstrating that
glucose deprivation promotes maintenance and repair in normal
cells while forcing cancerous cells to undergo apoptosis due to a
lack of energy (Li et al., 2010a).
ARE COMPOUNDS THAT HAVE LIFESPAN
EXTENSION PROPERTIES FUNCTIONING
THROUGH SIMILAR PATHWAYS TO CR?
Cellular nutrient sensing is complex, with multiple proteins
from several signaling cascades becoming active or repressed
in response to changes in the levels of nutrients such as
glucose, amino acids, hormones and cellular energy. Several
pharmacological agents and naturally occurring nutricueticals
can interact/inhibit/disrupt many of these proteins (Figure 3),
disrupting the ability of cellular nutrient sensing. But do these
compounds truly mimic CR?
RAPAMYCIN
In all model organisms tested thus far, caloric restriction has
been shown to significantly down regulate mTOR function
leading to increased autophagy and decreased protein translation
(Blagosklonny, 2010). However, there are compounds that are
hypothesized to mimic the effects of caloric restriction by
disrupting a cells ability to sense nutrients in their environment.
This is achieved as a result of mTOR inhibition, either
directly or via activation/inhibition of factors up-stream or
down-stream of mTOR complexes. The most well-known and
characterized of these inhibitors is rapamycin. Rapamycin, a
macrocyclic lactone-based compound, was first derived from the
bacterium Streptomyces hygroscopicus found in the soil of Easter
Island (Sehgal et al., 1975). Since its isolation, rapamycin has
become extensively used as an immunosuppressant following
organ transplantation (Dumont and Su, 1996). Rapamycin acts
primarily through the TOR pathway; in mammals, rapamycin
is bound between FKBP12 and the mTOR kinase subunits of
mTORC1, causing functional inhibition of mTOR and the mTOR
pathway (Dumont and Su, 1996). The downstream effects of this
inhibition include a decrease in cap-mediated protein translation
(Richter and Sonenberg, 2005) and an increase in autophagy
(Jung et al., 2010), both associated with promoting health
and lifespan. Rapamycin has been documented to ameliorate
age related-disease phenotypes of numerous cell-based models
(cancer; Shapira et al., 2006; Fang et al., 2011; Suzuki et al.,
2011), cardiovascular disease (Das et al., 2014), the premature
aging disease HGPS (Cao et al., 2011), neurodegenerative
diseases (Santos et al., 2011) and extend lifespan in numerous
model organisms including S. cerevisiae (Powers et al., 2006),
D. melanogaster (Bjedov et al., 2010), and M. muscularis (Miller
et al., 2011, 2014; Zhang et al., 2014).
The accumulation of cells in senescence has been extensively
linked to aging and the aging phenotype (Kong et al., 2011),
with clearance of senescent cells documented to improve
the symptoms of age-associated diseases (Baker et al., 2011).
Mesangial cells (MC) became senescent in response to high
glucose, increasing mTOR expression and decreasing SIRT1
expression (Zhang et al., 2012). It was demonstrated that
rapamycin interfered with MC senescence coincident with
increased SIRT1 expression (Zhang et al., 2012). In macrophages,
inhibition of SIRT1 resulted in over expression of inflammation-
related genes (TNF-α, IL-6) through NF-κB signaling activation.
Rapamycin ameliorated SIRT1 inhibition, reducing NF-κB
mediated inflammation (Takeda-Watanabe et al., 2012). The
senescence associated secretory phenotype (SASP) involves
secretion of pro-inflammatory cytokines from senescent cells
into the local tissues environment, causing deleterious effects to
surrounding cells and contributing to the aging process (Coppe
et al., 2010). It is possible that SIRT1 is essential in regulating
inflammation during the aging process, reducing inflammation-
linked signaling in response to rapamycin treatment and
promoting health and longevity. Similar evidence is present
in response to CR (Spaulding et al., 1997; Kalani et al., 2006;
Meydani et al., 2014).
Rapamycin has been extensively linked to cytokine expression
and regulation across multiple cell lines. In healthy human
foreskin fibroblasts [2DD], rapamycin caused up-regulation
of numerous genes, including cytokine genes from the IL-
6 signaling cascade, such as IL-6, IL-8, IL-11, and leukemia
inhibitory factor (LIF; Gillespie et al., 2015). Analysis of Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway terms
identified a specific enrichment of cytokine-cytokine receptor
interactions. Furthermore, transcription factor motif searches
of up-regulated promoters and subsequent chromatin immuno-
precipitation (ChIP) analyses demonstrated STAT5A/B as likely
mediating rapamycin-induced changes in gene expression
(Gillespie et al., 2015). Compounds that activate SIRT1 function
suppress pSTAT5A/B signaling in response to IL-2 and decrease
mouse and human T-cell proliferation (Gardner et al., 2013). In
orbital fibroblasts, rapamycin increased TNFα induced IL- 6 and
IL-8 secretion by suppressing programmed cell death 4 (PDCD4)
degradation (Lee et al., 2013), further increasing TNF, IL-6 and
decreasing IL-10 levels in human macrophages. Contrary to
this, in human oral keratinocytes (Su et al., 2015), rapamycin
suppresses TLR3 and subsequent NF-κB signaling, inhibiting
the production of interleukin-1 beta (IL-1β , TNFα, and IFN-
β ; but enhancing IL-12p70 production (Zhao et al., 2010).
Another study in senescent fibroblasts treated with rapamycin
similarly demonstrated a decrease in IL-6/cytokine production,
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FIGURE 3 | The downstream effects of CR mimetics and nutraceuticals on key aging mediators AMPK and SIRT1. Metformin exposure decreases
mitochondrial function, increasing AMP:ATP ratios of and levels of NAD+. Increased AMP:ATP ratio leads to activation of AMPK. AMPK is phosphorylated/activated
by LKB1 and SIRT1-mediated deacetylation, generating a feedback loop. AMPK inhibits glycogen synthesis, fatty acid oxidation, HMG-Co-A Reductase, and mTOR
function (indirectly through phosphorylation of the TSC1/2 complex; not shown). Decreased mTORC1 function results in; increased autophagy, decreased S6K activity
and cap mediated protein translation, inhibits HIF-1α, resulting in reduced cell cycle progression, angiogenesis, and glucose metabolism. Rapamycin mTORC1 kinase
activity, potentially mirroring the effects of Metformin. Through decreased mitochondrial function, Metformin increases NAD+ levels, promoting SIRT1 activity, resulting
in deacetylation of LKB1 and AMPK, and upregulated of their respective function. Polyphenols, Spermidine, and Aspirin increase SIRT1 activity, inducing deacetylation
of the RelA/p65 component of NFκB, preventing degradation of IκB and sequestering NF-κB in the cytoplasm, inhibiting proinflammatory gene expression. Cytokine
gene expression is repressed through SIRT1-mediated deacetylation and repression of STAT5A/B.
selectively suppressing translation of IL-1A (Laberge et al., 2015).
These findings provide further evidence of SASP and the impact
rapamycin may have on SASP to promote health and lifespan
in cells. The conflicting impact of rapamycin on repressing or
promoting gene expression/cytokine productionmay be complex
and influenced by cell type and cells state (proliferative vs.
senescent) in addition to the concentration and length of time
in which cells have been exposed.
As with CR, rapamycin could have the opposite effect on
cancer cells, resulting in cell death instead of promoting increased
maintenance and repair. In oral squamous cell carcinoma
(OSCC) Tca8113 and breast cancer cell lines, rapamycin
down-regulated expression of S-phase kinase associated protein-
2 (SKP2) and increased FOXO3a protein stability. When
combined with cisplatin, rapamycin induced the up-regulation
of feedback AKT activation-mediated FOXO3a phosphorylation
leading to accumulation of p27 and Bim, increasing apoptosis
(Shapira et al., 2006; Fang et al., 2011). The effects of rapamycin
on these cancerous cells is parallel to the impact of CR inducing
apoptosis previously identified. In healthy human cells, the
apoptosis-promoting properties of FOXO are attenuated by
SIRT1, further linking involvement of FOXO inhibition and
SIRT1 deacetylase activity in moving cells away from cell death
and toward survival (Giannakou and Partridge, 2004) in response
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to treatment with rapamycin and other longevity promoting
compounds.
Reports have linked CR with mTOR signaling, resulting in
increased expression of genes encoding proteins that protect
against oxidative damage. It is possible that rapamycin treatment
may induce similar effects. TOR function is associated with
decreased transcription of stress response genes in S. cerevisiae
via a mechanism involving Tap42 and the transcription factor
Msn2 (Vidan and Mitchell, 1997; Roosen et al., 2005; Swinnen
et al., 2006). Upon examination of rapamycin-treated mice
spermatogonial stem cells (SSC), oxidative stress response
genes were up-regulated (SOD1, glutathione reductase,
δ-aminolevulinate dehydratase; Kofman et al., 2012). In older,
wild-type mice, the expression of these genes was reduced. It
is possible to conclude that oxidative stress genes are induced
in response to rapamycin and may promote cellular longevity
in SSC cells from mice (Kofman et al., 2012), possibly priming
cells to manage alternative stresses, parallel to CR-mediated
hormesis. Pre-treatment of lung carcinoma cells (A549) with
rapamycin inhibited ROS and suppressed ROS-dependent
apoptosis (Suzuki et al., 2011). In human corneal endothelial
cells, rapamycin prevents cell-death as a result of oxidative injury
via inhibition of ROS production (Shin et al., 2011) and although
not directly reported, this was likely due to increased expression
of genes encoding oxidative damage proteins. Although this links
rapamycin to increasing health and lifespan, this link is divergent
to that observed in CR. CR may improve health/lifespan by
influencing protective enzymes, whilst rapamycin appears to
inhibit ROS production and induce oxidative response genes.
Some controversy exists over the extent to which rapamycin
impacts genome function in terms of gene expression. In healthy
human fibroblasts treated with rapamycin for 5 days, 537 genes
were identified by RNA sequencing with greater than five-fold
change in expression (Gillespie et al., 2015); however, in the
epididymal white adipose tissue of mice treated with rapamycin
for 6 months, just 6 down-regulated genes were identified (Fok
et al., 2014). This further supports the idea that rapamycin
induces species/cell-type specific responses. It could also indicate
that response to rapamycin is time specific, or even that the lack
of genes significantly altered by long-term rapamycin treatment
is the result of cells acclimatizing to long-term exposure. This
is further supported through studies that document chronic
exposure to rapamycin inducing inhibition of TORC2 under the
same concentrations that only activate TORC1 under short-term
exposure (Sarbassov et al., 2006).
Genome organization is tightly linked to genome function
which not only includes interactions between specific
genes/regulatory elements (Tolhuis et al., 2002; Schoenfelder
et al., 2010; Zhou et al., 2014) but also the re-positioning of
chromosome territories within the nuclear volume of cells.
Chromosome territories rapidly re-locate in dermal fibroblasts
in response to both quiescence induction via reduced serum
and as cells become senescent (Mehta et al., 2010, 2011). The
dynamic and rapid nature of this reorganization demonstrates
the responsiveness of the genome to external stimuli. In the
premature aging disease HGPS, treatment with rapamycin
resulted in chromosomes re-positioning to a similar state to
that of healthy cells, coincident with an improvement in disease
phenotype (Cao et al., 2011). Furthermore, in healthy human
fibroblasts, rapamycin induced repositioning of chromosomes
10 and 18 toward a more quiescent-like organization in parallel
with an increase in population doubling times (Gillespie et al.,
2015). The rapamycin-induced re-positioning of chromosomes
was coincident with a significant change in gene expression.
These findings link rapamycin-mediated inhibition of mTOR,
chromosome territory positioning and gene expression profiles
with the rate of cell growth. Furthermore, cells from HGPS
patients lack heterochromatin and exhibited decreased DNA
repair kinetics. This HGPS-associated loss of heterochromatin
is parallel, although accelerated, to that occurring in normal
aged cells. Cao and colleagues demonstrated that rapamycin
restored heterochromatin domains in HGPS cells and DNA
repair kinetics following the autophagy mediated degradation
of the cytotoxic Progerin protein (Musich and Zou, 2011). This
restoration of heterochromatin and DNA repair resulted in
increased cellular lifespan. It is likely that changes in genome
organization and the maintenance of heterochromatin will be
observed under conditions of CR or as a result of CR mimetics
that force changes in gene expression.
POLYPHENOLS
Polyphenols are portrayed as nutraceuticals in the media for
their ability to act as free radical scavengers. This scavenging
ability is due to the aromatic rings that are able to distribute
charge over the molecule. It is theorized that ingested
polyphenols are bioavailable in cells resulting in decreased
metabolic ROS byproducts, reducing damage to molecules
such as DNA. This scavenging ability is far from the only
health promoting properties these molecules have. There are a
number of naturally occurring polyphenols, including curcumin
(Jobin et al., 1999), apigenin (Wang et al., 2014), quercetin
(Endale et al., 2013), silymarin (Saliou et al., 1998), and
(my favorite) 2α,5-epoxy-5,10-dihydroxy-6α-angeloyloxy-9β-(3-
methylbutyloxy)-germacran-8α,12-olide (EDAG; Lee et al., 2011)
that function to inhibit inflammation. Under conditions that
induce inflammation, such as lipopolysaccharide treatment, NF-
κB is released from its inhibitor IκB, translocates to the nucleus
and promotes pro-inflammatory transcription. Collectively these
polyphenolic compounds prevent the degradation of IκB,
blocking NF-κB function and the inflammatory response. A
comprehensive examination of the impact of several polyphenols
on NF-κB signaling demonstrated, however, that differing
conditions or cell types, such as intestinal Coca-2 cells, may have
opposite effects (Romier et al., 2008).
RESVERATROL
Resveratrol (3,5,4′-trihydroxystilbene), is a well-known
polyphenol commonly found in a variety of foods, including
a number of berries, peanuts, grapes and red wine (Stervbo
et al., 2007). In fact, the presence of resveratrol in red wine has
been linked to the decreased levels of cardiovascular disease in
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the French population (Renaud and de Lorgeril, 1992). It has
since been documented that resveratrol has beneficial effects on
cancer, including the prevention of carcinogenesis in mice, and
the reduction in proliferation in a number of cancer-based cell
lines (prostate; Narayanan et al., 2003; Jones et al., 2005, ovarian;
Yang et al., 2003, breast; Chin et al., 2014). Given that both cancer
and cardiovascular disease are considered as age-related diseases,
the consideration of resveratrol as a potential intervention
for age-related diseases is realistic, with evidence already
implicating resveratrol as beneficial across numerous areas of
aging (e.g., cognitive aging in mice; Torres-Perez et al., 2015).
Although it has been suggested that resveratrol has no impact on
lifespan (Bass et al., 2007), several studies have reported lifespan
extension across a number of model organisms, such asN. furzeri
(a short-lived seasonal fish; Valenzano et al., 2006), S. cerevisiae
(Howitz et al., 2003), C. elegans, and D. melanogaster (Wood
et al., 2004). The mechanisms for this resveratrol associated
lifespan extension are thought to be centered around activation
of Sirtuin deacetylases (whether this activation be direct or
indirect; Pacholec et al., 2010), which are linked to CR-mediated
lifespan extension.
Resveratrol may also promote increased health by altering
gene expression patterns. In the prostate cancer cell line,
LNCaP, 1656 transcripts were identified as changing greater
than two fold expression in response to resveratrol treatment,
37% up-regulated and 63% down-regulated (Jones et al., 2005).
This change in transcript profile was coincident with a decrease
in cell proliferation. Multiple labs have demonstrated that
resveratrol impacts both the androgen (Narayanan et al., 2003;
Jones et al., 2005; Wang et al., 2008) and estrogen (Gehm
et al., 1997; Wang et al., 2008) receptor pathways. Androgens
mediate development and physiological responses and have been
associated with cellular functions such as cell cycle regulation,
transcription, cell proliferation and differentiation, including
down-regulation of prostate specific antigen (PSA; Jones et al.,
2005; Wang et al., 2008) and AR and the AR co-activator
ARA (Narayanan et al., 2003; Jones et al., 2005). Resveratrol
may be altering expression of genes via inhibition of androgen
and estrogen receptor-dependent signaling pathways (Wang
et al., 2008). Resveratrol, via activation of FOXO transcription
factors, induces growth arrest and apoptosis in LNCaP, with
in vitro experiments inducing decreased tumor apoptosis and
increased tumor angiogenesis despite initially delaying tumor
growth (Wang et al., 2008; Chen et al., 2010). These observations,
as well as others, demonstrate that resveratrol induces gene
expression profiles that promote cell death in a number of
cancer cell lines (Hsieh et al., 1999; Young et al., 2005; Chin
et al., 2014). SIRT1 has been identified to deacetylate both
the androgen (Fu et al., 2006) and estrogen (Yao et al., 2010)
receptors in addition to FOXO proteins [notably resveratrol
treatment induces expression of FOXO transcription factors,
with SIRT1/FOXO demonstrated to be responsible for increased
endothelial NO synthase (eNOS) which increases nitric oxide
(NO) production and is attributed to improving cardiovascular
health; Xia et al., 2013]. Given the proposed impact of SIRT1
activation, resveratrol could promote cell death of cancers
by interfering with the expression of androgen and estrogen
mediated genes as well as activating pro-apoptotic genes (such
as BIM; Chen et al., 2010) through FOXO-mediated DNA
binding.
In cancerous cell lines, the cytoprotective genes NQ01 (Yang
et al., 2003; Jones et al., 2005), and PRDX1, as well as MGST1
and GSTA2 were induced by resveratrol treatment (Jones et al.,
2005). These genes are transcribed by NRF2, a member of
the NRF transcription factor family. SIRT1 deacetylates NRF
family members, therefore, it could be that the induction of
these genes in response to resveratrol is the result of SIRT1
activation of NRF2. Furthermore, JUNB, HSP40, SERP1, and
STCH were up-regulated in response to resveratrol, indicating
cellular stress, with resveratrol inducing cell cycle arrest and
apoptosis at higher doses (Jones et al., 2005). Low levels
of resveratrol may prime cells to deal with DNA-damage
causing agents; however, at higher levels become a stress
itself.
Resveratrol may also mirror the function of CR and promote
health and longevity at the genetic level by interfering with
pro-inflammatory signaling pathways. In healthy cells and
tissues, resveratrol is able to block TNF-induced activation of
the nuclear transcription factor NF-κB, which regulates genes
involved in inflammation, cytoprotection and carcinogenesis
(Busch et al., 2012). This is likely through the activation of
SIRT1 mediated deacetylation of the p65/RelA subunit of NF-κB.
In human tenocytes, resveratrol suppressed IL-1b induced
activation of NF-κB and PI3K, inhibiting genes involved in
inflammation and apoptosis (Busch et al., 2012). Resveratrol
further inhibited IL-1b induced NF-κB and PI3K activation
through inhibition of IKK, IκBa phosphorylation and inhibition
of nuclear translocation of NF-κB, implicating PI3K signaling
as involved in the downstream impact of resveratrol (Busch
et al., 2012; Ren et al., 2013). Resveratrol, as with other mimetics
of CR, has been documented to have varied effects between
healthy and cancer cell lines. In myeloid cells (U-937), Jurkat
and epithelial cells (Hela and H4) resveratrol suppressed TNF-
induced phosphorylation and nuclear translocation of p65/RelA.
Also suppressed by resveratrol are AP-1,TNF-induced activation
of mitogen-activation protein kinase kinase (MAPKK), TNF-
induced cytotoxicity and caspase activation (Manna et al., 2000).
Resveratrol activated p53 and influenced gene expression in
LnCaP cells, impacting 34 transcripts being either up- or down-
regulated. Many of the transcripts were involved with apoptosis
[including programmed cell death factor 2 (PDCD-2), p300,
Apaf-1, CPP32, PIG 7, PIG8, BAK protein, and p57(Kip2)]
(Narayanan et al., 2003), with resveratrol further impacting
gene expression (Le Corre et al., 2006), decreasing proliferation
(Delmas et al., 2000), and inducing apoptosis (Niles et al., 2003)
in a number of human cancers. This change in gene expression
was coincident with decreased activation of NF-κB (Narayanan
et al., 2003). Genes involved in DNA damage, cell cycle and
oxidative stress were were also noted to be down regulated
(Narayanan et al., 2003). These observations demonstrate that
resveratrol is able to mimic CR by SIRT-mediated deacetylation
of pro-inflammatory complexes such as NF-κB in normal cells
while possibly having the opposite pro-apoptotic effect in cancer
lines.
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CATECHINS
In Japan, subpopulations are long-lived; this may be due to
the ingestion of large quantities of green tea enriched for in
polyphenolic compounds. One of the most well studied of
these polyphenolic compounds is (-)-epigallocatechin-3-gallate
(EGCG). Like other polyphenols, it has free radical scavenging
capabilities and inhibits NF-κB mediated inflammatory
responses in a variety of systems (Akhtar and Haqqi, 2011; Han
et al., 2012; Jiang et al., 2012), undoubtedly a major factor in this
observed longevity. However, EGCG has other ascribed impacts
that may contribute to increased longevity. EGCG reduces
levels of adipogenesis-related transcriptional factors, such as
C/EBPβ and PPAR, of differentiating 3T3–L1 preadipocytes
(Kao et al., 2006). EGCG treatment of breast cancer cells
can reactivate estrogen receptor (ER)-α through a reversal of
epigenetic silencing, leading to apoptosis (Li et al., 2010b). In
addition EGCG also directly and indirectly inhibits DNA methyl
transferases (DNMTs) causing the loss of methylation from the
p16ink promoter, retinoic acid receptor β (RARβ), and the DNA
mismatch repair gene human mutL homolog 1 (hMLH1). EGCG
also promotes the repression of the gene encoding for a subunit
of the human telomerase enzyme, hTERT, resulting in cancer cell
senescence (Berletch et al., 2008), similar to suppression induced
by glucose restriction of lung fibroblasts (Suzuki et al., 2011). A
comprehensive review of EGCG functions and modes is given
by Singh and colleagues describing the impact of this compound
on cell cycle inhibition, apoptosis and growth factor signaling
(Singh B. N. et al., 2011; Singh H. et al., 2011).
Unlike rapamycin or resveratrol, polyphenols in general may
not promote longevity per se, but have anti-cancer properties. For
example, genistein also stimulated the loss of hTERT expression
by increasing H3K9me3 and decreasing H3K4me2 within the
promoter region, preventing E2F-1-mediated transcriptional
activation (Li et al., 2009), leading to decreased cancer cell
proliferation. In addition, many of the actions of EGCG are
related to promoting apoptosis or senescence of cancer cells
through changes in epigenetic status (Berletch et al., 2008; Singh
H. et al., 2011). Although these compounds are exciting potential
chemotherapeutic agents, they may not be directly acting as
anti-aging compounds.
METFORMIN
Metformin, a compound derived from the French
Lilac (G. officinalis) and chemically known as N,N-
Dimethylimidodicarbonimidic diamide, is a guanidine-based
hypoglycemic agent commonly used in treating patients with
type II diabetes (T2D; Witters, 2001) by inhibiting hepatic
gluconeogenesis and decreasing insulin levels (Hundal et al.,
2000; Zhou et al., 2001). Despite being such a widely used
compound, the specific mechanisms by which metformin act
at the molecular/cellular level remain unconfirmed. Regardless,
evidence does indicate that metformin functions, at least in
part, via an AMPK-dependent pathway (Zhou et al., 2001). It
is unlikely that metformin directly binds to either AMPK or its
activator LKB1 as the drug does not affect phosphorylation of
AMPK by LKB1 in a cell-free assay (Hardie, 2006). Metformin
likely influences AMPK levels by modulating ATP production
by mitochondria. Evidence to support this hypothesis indicates
that metformin induces mild and specific inhibition of the
mitochondrial respiratory-chain complex I (El-Mir et al., 2000;
Owen et al., 2000). Metformin has further been suggested
to act through a number of AMPK-independent pathways
such as via DNA-damage inducible transcript 4 (DDIT-4; Ben
Sahra et al., 2011). Although the positive health benefits in
regards to T2D and potentially health and lifespan are well
documented, how this is facilitated through numerous pathways
and secondary effects is unclear. This metformin-mediated
disruption of mitochondrial function may parallel CR through
increased AMP:ATP ratios leading to AMPK activation (Canto
and Auwerx, 2011) and mTOR inhibition.
Recent evidence has highlightedmetformin as both a potential
anti-cancer agent and as a promising target in promoting
increased health and lifespan. Numerous studies report increased
apoptosis and decreased proliferation of various cancer cell lines
(e.g., lung; Ashinuma et al., 2012, retinoblastoma; Brodowska
et al., 2014, and oesophageal squamous cell carcinoma; Feng
et al., 2014) in response to metformin, and T2D patients treated
with metformin have a lower incidence of cancer compared
to control groups (Evans et al., 2005). This is promising given
the extensive links between cancer and aging; however, healthy
model organisms treated with metformin have shown varied
responses, with lifespan extension occurring inC. elegans (Onken
and Driscoll, 2010; Cabreiro et al., 2013) and M. musculus
(Martin-Montalvo et al., 2013), whilst D. melanogaster (Slack
et al., 2012) and R. norvegicus (Smith et al., 2010) demonstrated
no change.
What impact does metformin have on genome function to
promote health? Under conditions of excess nutrients AMPK and
SIRT1 are down regulated. Metformin results in the activation
of both these proteins (Nelson et al., 2012; Arunachalam et al.,
2014) similar to CR (Cohen et al., 2004; Canto and Auwerx,
2011). The metformin-mediated activation of AMPK and SIRT1
deacetylation of p53 decreases its function in the human hepatic
carcinoma cell line, HepG2 (Nelson et al., 2012). In addition,
metformin appears to reduce levels of oxidative stress, impeding
p53 activation. It also decreased a trigger for p53 accumulation,
cytosolic oxidative stress and increased deacetylation of p53
at a SIRT1 targeted site (Nelson et al., 2012). Furthermore,
mouse microvascular endothelial cells (MMEC) that had been
exposed to high glucose were treated with metformin. This
treatment up-regulated SIRT1 expression which is normally
repressed by high glucose, modulating downstream targets of
SIRT1 (FoxO1 and p53/p21) and protecting endothelial cells from
entering premature senescence (Arunachalam et al., 2014). In
blood mononuclear cells (MNC) of patients with carotid artery
atherosclerosis, metformin ameliorates the pro-inflammatory
response decreasing IL-6, TNF-α mRNA levels and attenuated
NF-κB DNA binding activity (Xu et al., 2015). Metformin did
not alter p65/RelA protein levels but resulted in decreased
acetylation, likely through SIRT1-mediated deacetylation (Xu
et al., 2015). Additionally, Saa1 and Saa2 genes, associated with
the inflammatory response, are down-regulated in the muscle
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and liver of metformin-treated mice. A decrease in inflammatory
markers (attenuated expression of the NF-κB gene, resulted
in decreased NF-κB and JNK) was also observed (Martin-
Montalvo et al., 2013). This is coincident with a significant up-
regulation of cytokine-inducible SH2-containing protein (CISH), a
negative regulator of cytokine signaling (Martin-Montalvo et al.,
2013). Metformin has also been associated with the induction
of stress-response and antioxidant-linked proteins, including
SOD2, TrxR1, NQ01 and NQ02 in mice livers (Martin-Montalvo
et al., 2013). Furthermore, metformin treatment decreased
production of IL-1β, increased induction of anti-inflammatory
IL-10 and inhibited ROS in macrophages (Algire et al., 2012;
Kelly et al., 2015). Contradictory to CR, metformin resulted in
increased levels of ROS which up-regulated the expression of
the UCP2 transcripts in epididymal white adipose tissue of mice
or in 3T3-L1 adipocytes (Anedda et al., 2008). Taken together,
these data indicate that metformin may inhibit multiple pro-
inflammatory pathways, through activation of SIRT1 and the
repression of NF-κB in addition to the up-regulation of CISH, as
part of the mechanism influencing health and longevity. As with
rapamycin and CR, however, different systems and cell types may
result in differing responses.
The expression of the Selenoprotein P (SeP) encoding SEPP1
gene leads to increased potential in developing T2D (Takayama
et al., 2014). Promoter analysis and subsequent reporter assays of
this gene demonstrates binding sites for FOXO3a to facilitate the
expression of this gene. Metformin treatment disrupted FOXO
mediated expression of this gene through direct phosphorylation
by activated AMPK (Takayama et al., 2014). Daf-16 knockouts
in C. elegans leads to increased lifespan by disruption of the
insulin-like pathway (Greer and Brunet, 2005). CR results in
FOXO3a hyperphosphorylation by AMPK and its exclusion
from the nucleus. Metformin-mediated activation of AMPK also
leads to hyperphosphorylation of FOXO3a, nuclear exclusion
and up-regulation of mitochondrial gene expression (Greer
and Brunet, 2005). However, knockout of daf-16/FOXO still
resulted in an increase in median lifespan, demonstrating that
this transcription factor is dispensable for metformin mediated
lifespan extension (Onken and Driscoll, 2010). Therefore,
metformin may be acting through a CR conferred pathway. In
eat-2 knock-outs (which impair the ability of worms to feed)
treated with metformin, no health or lifespan benefits were
observed and detrimental effects similar to those of extreme CR
were documented. Regardless, the extension of lifespan requires
functional AMPK (Onken and Driscoll, 2010) indicating that this
is a critical molecule in metformin mediated lifespan extension.
Knockout and mutational analysis of the C. elegans homolog
of AMPK, aak-2, demonstrates that this protein is essential for
metformin-associated lifespan extension (Onken and Driscoll,
2010). Furthermore, the protein threonine kinase, LKB1,
directly phosphorylates and activates AMPK in response
to metformin. In C. elegans, PAR-4 (the LKB1 homolog)
mutants treated with metformin conferred no health or
lifespan benefits (Onken and Driscoll, 2010) demonstrating
the importance of this kinase in mediating AMPK function.
In the absence of this LKB1 activity, metformin treatment
resulted in decreased lifespan. LKB1 inactivation has been
suggested to be regulated by SIRT1, influencing its cytosolic
localization, association with the LKB1 activator STE20-related
adaptor (STRAD), kinase activity and its ability to activate AMPK
(Lan et al., 2008). This links the interplay between AMPK,
LKB1, and SIRT1 as key mediators of longevity across model
organisms.
To ascertain what impact metformin treatment is having
genome-wide, transcript profiles from LoVo colon cancer cells
were assessed by microarray analysis (He et al., 2015). At 8 h,
10mM metformin resulted in 134 differentially expressed genes,
whilst at 24 h 3061 genes altered expression. Concentration of
metformin also demonstrated alternative impacts on health and
lifespan with 0.1% (w/w) metformin in the diets of C57BL/6
increasing lifespanwhilst 1% (w/w)metformin decreased lifespan
(Martin-Montalvo et al., 2013). In B6C3F1 mice, lifespan
extension was also observed; however, the levels were less
significant (Martin-Montalvo et al., 2013). Microarray analyses
of the muscle and liver cells of metformin-fed mice revealed a
transcriptome profile shifting toward that, but not identical to,
caloric restriction by 30 weeks. Although CISH was consistently
one of the most up-regulated genes in both tissues (Martin-
Montalvo et al., 2013), other genes were up-regulated in one
but not the other (e.g., SOCS2 up-regulated in liver, DDIT4
in muscle). Therefore, the effects of metformin are not only
strain/tissue-, dose- and time-dependent, but may also not
directly mimic CR.
Gene ontology (GO) term enrichment of LoVo cells
treated with metformin revealed up-regulated genes enriched
for processes such as RNA processing and regulation of
cellular protein metabolic process whilst down-regulated genes
demonstrated enrichment for various cell cycle processes at 8 h.
At 24 h, up-regulated genes were enriched for in pathways of cell
activity (e.g., protein modification, induction of apoptosis and
response to reactive oxygen species; He et al., 2015). Microarray
analysis of mouse liver tissues following 0.1% (w/w) metformin
treatment revealed down-regulation of genes associated with
autophagy, and apoptosis in mice (Martin-Montalvo et al., 2013).
Although this is an opposite impact to that observed in LoVo
cells, it is logical and in agreement with the proposal that
metformin induced apoptosis in cancer cell lines, whilst in
healthy tissues, promotes cell survival, likely via SIRT1/FOXO
axis.
SPERMIDINE
In general, polyamines are polycationic molecules that interact
with negatively charged polymers such as DNA, RNA and
proteins and can be found in a large number of eukaryotic and
prokaryotic organisms (reviewed in Minois, 2014). Polyamines
decrease with aging in several mouse tissues (Nishimura
et al., 2006) and in the aging human basal ganglia (Vivo
et al., 2001). Although polyamines, including spermidine,
are naturally produced within cells, ingestion of polyamines
from the diet can impact gene expression and chromatin
organization associated with increased healthspan and longevity
(Minois et al., 2011). The specific mechanisms by which these
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molecules facilitate changes in gene expression are indirect or
have not been elucidated. Like CR, and other nutraceuticals
that impact lifespan, spermidine reduces the expression of
pro-inflammatory genes. This suppression of pro-inflammatory
genes is hypothesized to be the result of sequestered NF-κB
subunit p65 in the cytoplasm, preventing the activation of
target genes (Choi and Park, 2012). In 3T3-L1 cells, spermidine
has been shown to directly interact with the acidic nuclear
phosphoprotein 32 (ANP32; Hyvonen et al., 2013). Upon
spermidine interaction, ANP32 releases the RNA binding
protein HuR which then binds and facilitates the translation
of C/EBP-b. This increase in C/EBP-b speculated to further
drive the expression of genes encoding the transcription factors
PPAR-γ and SREBP-1c leading to adipocyte differentiation
(Hyvonen et al., 2013). Furthermore, transcriptome profiling of
cells depleted of polyamines demonstrated increased expression
of cell cycle control proteins p21, Mdm2, and Gadd45 as
well as reduced expression of cyclin D1 (Landau et al.,
2012). However, it is unclear if these changes were secondary
effect of polyamine depletion activating the unfolded protein
stress response. These stress responses and resumption of
cell growth were quickly reversed upon the addition of
spermidine.
Spermidine also appears to impact global acetylation levels of
histones. In yeast, all histone H3 lysine residues studied showed
decreased levels of acetylation following spermidine treatment
in addition to decreased levels of ROS. This hypoacetylation is
believed to be due to spermidine mediated inhibition of histone
acetyl transferases (HATs) leading to increased expression of
the autophagy-related ATG genes (Eisenberg et al., 2009).
Furthermore, keratinocytes from mice over-expressing enzyme
promoting spermidine production demonstrated an overall
reduction in acetylation levels indicating a further impact on
gene expression. Although this decrease in acetylation levels
as well as the inhibition of NF-κB is reminiscent of SIRT1
activation, recent research has proposed that spermidine and
other SIRT1 activators (such as resveratrol) function via differing
pathways, but both impacting global protein acetylation (Morselli
et al., 2011). Spermidine also has a complex nature with regards
to cancer cells. In some cancers polyamines synthesis is up-
regulated resulting in an indirect increase p300-associated HAT
activity, altering chromatin structure favoring neoplastic process
(Hobbs et al., 2002).
ASPIRIN
Aspirin, also known as acetylsalicylic acid (ASA), is a member
of the non-steroidal anti-inflammatory (NSAID) drug family
and is well known for its inhibitory effect on COX-2 gene
expression. COX-2 encodes the cyclooxygenase 2 enzyme which
functions to convert arachidonic acid to prostaglandins which
further function in pain and inflammatory responses. Nuclear
translocation of activated NF-κB promotes the transcription of
target genes such as Cox-2, iNOS, VCAM-1, and ICAM-1. Low
doses of ASA fed to old rats appeared to ameliorate the NF-κB-
mediated pro-inflammatory response in kidneys by preventing
IκB degradation, leading to cytoplasmic retention of NF-κB
(Jung et al., 2006). In addition, ASA also appeared to inhibit
the nuclear translocation of the complex containing thioredoxin
(Trx) and redox factor-1 (Ref-1) which enable DNA binding of
NF-κB. Investigation into other compounds closely related to
ASA from the NSAID family have focused on the impact of
these drugs on NF-κB function. Furthermore, treatment of breast
cancer cells with the physiological achievable concentration of
100µMASA increased levels of p53 acetylation and increased the
expression of p21CIP (cell cycle arrest) and Bax (pro-apoptotic).
ASA may further increase health and lifespan by inducing the
expression of pro-apoptotic genes in cancer cells. For example,
ASA has been documented to up regulate calpain expression
in cervical carcinomas. Calpains are a class of non-lysosomal
cysteine proteases involved with a number of cellular processes
including glucose homeostasis. Furthermore, calpains exhibit
cross talk with the pro-apoptotic protease caspase-3 (Lee et al.,
2008). However, the response of cells/tissues to ASA may not
be straight forward. Microarray analysis of HT29 colon cancer
cells demonstrates significantly different transcriptome profiles
when treated with 50 µM, 500 µM, or 5mM of ASA (Hardwick
et al., 2004). These observations indicate that ASA is potentially
useful as a chemo-preventative agent for cancers and, therefore,
involved in promoting health, but the dose of the compound
may alter gene expression profiles leading to alternative, possibly
undesired outcomes. In addition, risk-benefit research into the
use of ASA indicates that patients with disease that make them
prone to cancers, such as familial adenomatous polyposis or
Lynch syndrome, are not protected (Alfonso et al., 2009). Other
cancer types, such as adenomas, do show statistically significant
alterations in response to ASA. These observations, indicate
that ASA does promote changes in genome function leading to
increased health and possibly the prevention of specific cancers;
however, this role in specifically increasing longevity per se is
unclear.
CONCLUSIONS
It is clear that CR results in decreased energy and changes
in cellular AMP:ATP and NAD:NADH ratios. Compounds
that mimic CR do so by impacting cellular function resulting
energy readouts or interfering with signaling down-stream
cellular energy levels. The main proteins that appear central
to mediating this response are AMPK and SIRT1 which
regulate cycles of deacetylation and phosphorylation of a large
number of cytosolic and nuclear proteins to control gene
expression and cellular functions. Many of the CR mimetics
of naturally occurring compounds identified either modulate
SIRT1/AMPK function or, for example with rapamycin, target
downstream signaling hubs to mediate potential health and
lifespan effects. Of these targets NF-κB and the FOXO family
of transcription factors, are pivotal in promoting decreased cell
proliferation and increased maintenance in normal cells, while
facilitating apoptosis and cell death in cancer cells. Furthermore,
although all compounds appear to confer life and healthspan
extending impacts across numerous cell types and model
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organisms via this SIRT1/AMPK interaction, the downstream
impact on genome function (gene expression) is varied, across
cell-type, organism-type, and compound-type in addition to
variations in experimental details (such as exposure times,
drug concentrations). This suggests that although mechanisms
mediating health and lifespan in response to CR and these
compounds are similar, the effects on gene expression mean that
these compounds may not be direct mimetics of CR or of one
another.
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